Benjamin Mark Schleiff
Researcher
University of Arkansas for Medical Sciences
unknown
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Benjamin Mark Schleiff's research investigates the bioactivation and detoxification pathways of diphenylamine nonsteroidal anti-inflammatory drugs (NSAIDs). His work has identified opposing roles for CYP2C9 and CYP3A4 enzymes in these processes. Schleiff has published three papers, accumulating 26 citations and an h-index of 3. His collaborations include researchers at the University of Arkansas for Medical Sciences, such as Grover Miller and Gunnar Boysen, with whom he has co-authored multiple publications. His recent activity indicates ongoing engagement in this area of study.
Metrics
- h-index: 3
- Publications: 3
- Citations: 26
Selected Publications
- CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs (2021) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics